Identification
- Summary
Hops is an extract from Hops used in allergy testing.
- Generic Name
- Hops
- DrugBank Accession Number
- DB10687
- Background
Hops allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Hops Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US 
Hops Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Hops Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Hops Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US Hops Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Detente - Cap 150mg Capsule 150 mg / cap Oral Laboratoire Lalco Inc. 1997-01-20 2002-09-05 Canada 
Florasun Houblon Cap 150mg Capsule 150 mg / cap Oral Laboratoire Lalco Inc. 1995-12-31 2000-08-01 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Herbal Nerve Tab Hops (50 mg) + Scutellaria lateriflora (100 mg) + Valerian (50 mg) Tablet Oral Vita Health Products Inc 1977-12-31 2005-07-20 Canada Herbal Sleep Hops (165 mg) + Chamomile (100 mg) + Passiflora incarnata flower (175 mg) + Valerian (600 mg) Capsule Oral Puresource Inc. Not applicable Not applicable Canada Herbal Sleep Aid Hops (100 mg) + Passiflora incarnata flower (100 mg) + Valerian (400 mg) Capsule Oral Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. 1998-11-05 2002-07-29 Canada Herbal Slumber Cap Hops (67 mg) + Peppermint (153 mg) + Scutellaria lateriflora (153 mg) + Valerian (177 mg) Capsule Oral Pep Products Inc. 1992-12-31 1999-10-29 Canada Hops-valerian Combination Cap Hops (134 mg) + Scutellaria lateriflora (133 mg) + Valerian (133 mg) Capsule Oral Nature's Herbs Inc. 1995-12-31 1997-05-30 Canada
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 01G73H6H83
- CAS number
- Not Available
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Oral 150 mg / cap Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Capsule Oral Powder Oral Tablet Oral Tablet, coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at April 23, 2024 11:38